Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 21.3713.5264.41--

What is the latest Core EBITDA Growth ratio of AARTI PHARMALABS ?

The latest Core EBITDA Growth ratio of AARTI PHARMALABS is 21.37 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202521.37
Mar202413.52
Mar202364.41
Mar2022-
Mar2021-

How is Core EBITDA Growth of AARTI PHARMALABS Trending?

Years Core EBITDA Growth % Change
Mar2025 21.37
58.06
Mar2024 13.52
-79.01
Mar2023 64.41
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Growth ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹7,632.1 Cr 1.8% -6.5% 31.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,140.0 Cr 2.1% 2.4% -11.5% Stock Analytics
DIVIS LABORATORIES ₹175,290.0 Cr 0.7% 8.2% 8.1% Stock Analytics
CIPLA ₹132,417.0 Cr 5.6% 3.9% 1% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,839.0 Cr 1.5% 0.1% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,031.0 Cr 3.7% -3% -6.4% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

1.8%

-6.5%

31.1%

SENSEX

2.5%

2%

3.1%


You may also like the below Video Courses